Bioventus (BVS)
(Delayed Data from NSDQ)
$11.79 USD
-0.16 (-1.34%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $11.78 -0.01 (-0.08%) 7:58 PM ET
1-Strong Buy of 5 1
C Value A Growth F Momentum B VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/5/24 |
---|---|
Current Quarter | 0.06 |
EPS Last Quarter | 0.19 |
Last EPS Surprise | 171.43% |
ABR | 2.33 |
Earnings ESP
|
0.00% |
---|---|
Current Year | 0.40 |
Next Year | 0.45 |
EPS (TTM) | 0.38 |
P/E (F1) | 29.88 |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 132.57M | 147.53M | 560.78M | 593.28M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 132.57M | 147.53M | 560.78M | 593.28M |
Low Estimate | 132.57M | 147.53M | 560.78M | 593.28M |
Year ago Sales | 120.79M | 135.42M | 512.34M | 560.78M |
Year over Year Growth Est. | 9.75% | 8.94% | 9.45% | 5.80% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 0.06 | 0.09 | 0.40 | 0.45 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | NA | NA | NA | NA |
High Estimate | 0.06 | 0.09 | 0.40 | 0.45 |
Low Estimate | 0.06 | 0.09 | 0.40 | 0.45 |
Year ago EPS | 0.05 | 0.07 | 0.02 | 0.40 |
Year over Year Growth Est. | 20.00% | 28.57% | 1,900.00% | 12.50% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | 0.06 | 0.09 | 0.40 | 0.45 |
7 Days Ago | 0.06 | 0.09 | 0.40 | 0.45 |
30 Days Ago | 0.06 | 0.09 | 0.40 | 0.45 |
60 Days Ago | 0.06 | 0.09 | 0.27 | 0.43 |
90 Days Ago | 0.06 | 0.09 | 0.27 | 0.43 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | 0.06 | 0.09 | 0.40 | 0.45 |
Zacks Consensus Estimate | 0.06 | 0.09 | 0.40 | 0.45 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | 0.19 | 0.07 | 0.07 | 0.05 | NA |
Estimate | 0.07 | -0.05 | 0.06 | 0.06 | NA |
Difference | 0.12 | 0.12 | 0.01 | -0.01 | 0.06 |
Surprise | 171.43% | 240.00% | 16.67% | -16.67% | 102.86% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more